Determinants of glycemic control in female diabetic patients: A study from Iran

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Ghazanfari, Zeinab ^a   Niknami, Shamsaddin ^a   Ghofranipour, Fazlollah ^a   Larijani, Bagher ^b   Agha Alinejad, Hamid ^c   Montazeri, Ali ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY MASS; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GLYCEMIC CONTROL; HUMAN; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE; WOMEN'S HEALTH; ANTHROPOMETRY; BLOOD; DEMOGRAPHY; DIABETIC ANGIOPATHY; HYPERGLYCEMIA; MIDDLE AGED; OUTPATIENT DEPARTMENT; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE FACILITIES; ANTHROPOMETRY; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; IRAN; MIDDLE AGED; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 77955361700     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-83     Document Type: Article

References (29)

1. The effect of case management on glycemic control in patients with type 2 diabetes. J Middleton, The Case Manager 2003 14 43 47 10.1016/j.casemgr.2003. 09.007 14618148
2. Diabetes mellitus: a review of select ADA standards for 2006. JL Bevan, J Nurse Pract 2006 2 674 679 10.1016/j.nurpra.2006.07.001
3. Standards of medical care in diabetes - 2009. American Diabetes Association, Diabetes Care 2009 32 13 S61 10.2337/dc09-S013 19118286
4. Factors associated with poor glycemic control among patients with type 2 diabetes. M Khattab YS Khader A Al-Khawaldeh K Ajlouni, J Diabetes Complications 2003 24 84 89 10.1016/j.jdiacomp.2008.12.008
5. Glycated haemoglobin (HbA1c): today and tomorrow. L Roszyk B Faye V Sapin F Somda I Tauveron, Ann Endocrinol(Paris) 2007 68 357 365 10.1016/j.ando.2007. 06.004 17904515
6. What is the proper use of hemoglobin A1C monitoring in the elderly? T Alam N Weintraub J Weinreb, J Am Med Dir Assoc 2006 7 60 64 10.1016/j.jamda. 2005.12.017 16413436
7. Adherence and glycemic control among Hispanic youth with type 1 diabetes: Role of family involvement and acculturation. O Hsin AM La Greca J Valenzuela CT Moine A Delamater, J Pediatr Psychol 2010 35 156 166 10.1093/jpepsy/jsp045 19491214
8. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. IM Stratton AI Adler HA Neil DR Matthews SE Manley CA Cull D Hadden RC Turner RR Holman, BMJ 2000 321 405 412 10.1136/bmj.321.7258.405 10938048
9. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. JB Saaddine B Cadwell EW Gregg MM Engelgau F Vinicor G Imperatore KM Narayan, Ann Intern Med 2006 144 465 474 16585660
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998 352 837 853 10.1016/S0140-6736(98)07019-6 9742976
11. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. AJ Karter HH Moffet J Liu MM Parker AT Ahmed A Ferrara JV Selby, Am J Manag Care 2005 11 262 270 15839186
12. Factors that influence improvement for patients with poorly controlled type 2 diabetes. A Hartz S Kent P James Y Xu M Kelly J Daly, Diabetes Res Clin Pract 2006 74 227 232 10.1016/j.diabres.2006.03.023 16723163
13. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. AN Goudswaard RP Stolk P Zuithoff GE Rutten, Eur J Epidemiol 2004 19 541 545 10.1023/B:EJEP.0000032351.42772.e7 15330126
14. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. TM Wallace DR Matthews, QJM 2000 93 369 374 10.1093/qjmed/93.6.369 10873187
15. BMI classification. WHO, http://apps.who.int/bmi/index.jsp?introPage= intro-3.html
16. An automated immunoturbidimetric assay for HbA1c determination. M Vucic S Petrovic R Mesic B Rocic, Clin Chem Lab Med 1999 37 199 10.1515/CCLM.1999.037
17. Waist circumference, body mass index and glycated hemoglobin in Japanese men and women. D Yoshida K Toyomura J Fukumoto N Ueda K Ohnaka M Adachi R Takayanagi S Kono, Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2001 3 7 11 10.1016/j.dsx.2008.10.002
18. Abdominal obesity and ethnic differences in diabetes awareness, treatment, and glycemic control. IS Okosun GE Dever, Obes Res 2002 10 1241 1250 10.1038/oby.2002.169 12490668
19. Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes. MJ Blaha T Gebretsadik A Shintani TA Elasy, Obesity (Silver Spring) 2008 16 869 874 18277389
20. Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. H Nagaretani T Nakamura T Funahashi K Kotani M Miyanaga K Tokunaga M Takahashi H Nishizawa K Kishida H Kuriyama K Hotta S Yamashita Y Matsuzawa, Diabetes Care 2001 24 2127 2133 10.2337/diacare.24.12.2127 11723095
21. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. EJ Boyko WY Fujimoto DL Leonetti L Newell-Morris, Diabetes Care 2000 23 465 471 10.2337/diacare.23.4.465 10857936
22. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. JP Despres A Nadeau A Tremblay M Ferland S Moorjani PJ Lupien G Theriault S Pinault C Bouchard, Diabetes 1989 38 304 309 10.2337/diabetes.38.3.304 2645187
23. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. CS Fox JM Massaro U Hoffmann KM Pou P Maurovich-Horvat CY Liu RS Vasan JM Morabito JB Meigs LA Cupples RB D'Agostino CJ O'Donnell, Circulation 2007 116 39 48 10.1161/CIRCULATIONAHA.106.675355 17576866
24. Abdominal adiposity: Early intervention and therapeutic options. AJ Scheen, Clin Cornerstone 2008 9 20 27 10.1016/S1098-3597(08)80004-X
25. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. MB Davidson DL Schriger, Diabetes Res Clin Pract 2010 87 415 21 10.1016/j.diabres.2009.12.013 20061043
26. Determinants of glycated haemoglobin in the general population: associations with diet, alcohol and cigarette smoking. MC Gulliford OC Ukoumunne, Eur J Clin Nutr 2001 55 615 623 10.1038/sj.ejcn.1601233 11464236
27. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education. WB Chan JC Chan CC Chow VT Yeung WY So JK Li GT Ko RC Ma CS Cockram, QJM 2000 93 183 190 10.1093/qjmed/93.3.183 10751238
28. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes - data from the National Diabetes Register in Sweden. PM Nilsson S Gudbjornsdottir B Eliasson J Cederholm, Diabetes Metab 2004 30 261 268 10.1016/S1262-3636(07)70117-9 15223978
29. Glycemic control in older subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study. DG Bruce WA Davis TM Davis, J Am Geriatr Soc 2000 48 1449 1453 11083322